Senior Regulatory Expertise Across Precision Medicine, Diagnostics & Drug Development:
Blue Tulip Solutions brings together regulatory sciences, biomarker strategy, IVD/CDx development and executive advisory to address complex development and regulatory decisions across the life sciences ecosystem.
Blue Tulip Solutions combines the expertise of Haydar Celik, PhD, with a carefully selected network of strategic partners to provide comprehensive guidance in FDA regulatory science, precision medicine, genomics, commercialization, and healthcare innovation. Together, we help organizations move confidently from scientific discovery to regulatory approval and commercial success.
Founder & Principal
Regulatory Affairs Executive | Former FDA Reviewer | Precision Medicine | IVD & CDx

Global Regulatory Strategy
Precision Medicine & Biomarker Strategy
IVD & Companion Diagnostic Development
Drug-Diagnostic Co-development
Digital HealthAI-Driven Healthcare Innovation
Product Development & Commercialization
Executive & Board-Level Strategic Advisory
Blue Tulip can engage experienced collaborators with complementary expertise when additional speacialized support is needed.
Turn complex scientific and regulatory challenges into clear, actionable strategies. Blue Tulip Solutions helps life-science organizations reduce risk, strengthen product positioning, and accelerate the path from innovation to market. Our integrated approach connects science, regulation, and business to support confident decisions and sustainable growth.

Clear, practical regulatory strategies that align innovation, evidence, and business objectives from the earliest stages.

Early identification of regulatory, evidence, development and commercialization challenges to support more informed development decisions before they become costly delays.

Focused strategies that support efficient development, stronger submissions, and timely market entry.

Integrated scientific, regulatory, and business perspectives to shape compelling product, evidence generation, and market-access strategies that strengthen stakeholder alignment and investor confidence.

Integrated scientific, regulatory, and business perspectives to shape compelling product, evidence generation, and market-access strategies that strengthen stakeholder alignment and investor confidence.

Focused strategies that support efficient development, stronger submissions, and timely market entry.
Contact Blue Tulip to discuss your needs and discover how we can help you thrive.

Expert Consulting from Concept to Commercialization in Precision Medicine
(301) 919-8573
(301) 919-8573
Copyright 2026. Blue Tulip Solutions LLC. Privacy Policy. All rights reserved.